nodes	percent_of_prediction	percent_of_DWPC	metapath
Agomelatine—CYP1A2—Carmustine—malignant glioma	0.388	1	CbGbCtD
Agomelatine—HTR2C—choroid plexus—malignant glioma	0.0777	0.36	CbGeAlD
Agomelatine—MTNR1B—retina—malignant glioma	0.0307	0.142	CbGeAlD
Agomelatine—HTR2C—telencephalic ventricle—malignant glioma	0.0228	0.105	CbGeAlD
Agomelatine—MTNR1A—telencephalon—malignant glioma	0.0223	0.103	CbGeAlD
Agomelatine—Melatonin—ASMT—malignant glioma	0.0149	0.497	CrCbGaD
Agomelatine—MTNR1A—central nervous system—malignant glioma	0.0127	0.0588	CbGeAlD
Agomelatine—MTNR1A—brain—malignant glioma	0.0101	0.0467	CbGeAlD
Agomelatine—HTR2C—brainstem—malignant glioma	0.00616	0.0285	CbGeAlD
Agomelatine—HTR2C—telencephalon—malignant glioma	0.00547	0.0253	CbGeAlD
Agomelatine—HTR2B—telencephalon—malignant glioma	0.00514	0.0238	CbGeAlD
Agomelatine—Phosphatase alkaline increased—Temozolomide—malignant glioma	0.00476	0.035	CcSEcCtD
Agomelatine—HTR2C—medulla oblongata—malignant glioma	0.0043	0.0199	CbGeAlD
Agomelatine—Blood alkaline phosphatase increased—Temozolomide—malignant glioma	0.00397	0.0292	CcSEcCtD
Agomelatine—HTR2C—midbrain—malignant glioma	0.00393	0.0182	CbGeAlD
Agomelatine—Hepatic failure—Temozolomide—malignant glioma	0.00385	0.0282	CcSEcCtD
Agomelatine—HTR2C—spinal cord—malignant glioma	0.00383	0.0177	CbGeAlD
Agomelatine—Nabumetone—PTGS1—malignant glioma	0.00366	0.122	CrCbGaD
Agomelatine—Face oedema—Carmustine—malignant glioma	0.00345	0.0254	CcSEcCtD
Agomelatine—Face oedema—Temozolomide—malignant glioma	0.00334	0.0245	CcSEcCtD
Agomelatine—HTR2C—central nervous system—malignant glioma	0.00311	0.0144	CbGeAlD
Agomelatine—HTR2B—central nervous system—malignant glioma	0.00292	0.0135	CbGeAlD
Agomelatine—Depression—Carmustine—malignant glioma	0.00275	0.0202	CcSEcCtD
Agomelatine—Weight increased—Temozolomide—malignant glioma	0.00272	0.02	CcSEcCtD
Agomelatine—Weight decreased—Temozolomide—malignant glioma	0.0027	0.0198	CcSEcCtD
Agomelatine—Indomethacin—CXCL8—malignant glioma	0.00269	0.0895	CrCbGaD
Agomelatine—Infestation NOS—Temozolomide—malignant glioma	0.00266	0.0196	CcSEcCtD
Agomelatine—Infestation—Temozolomide—malignant glioma	0.00266	0.0196	CcSEcCtD
Agomelatine—Depression—Temozolomide—malignant glioma	0.00266	0.0195	CcSEcCtD
Agomelatine—Hepatobiliary disease—Temozolomide—malignant glioma	0.00252	0.0185	CcSEcCtD
Agomelatine—HTR2C—brain—malignant glioma	0.00247	0.0114	CbGeAlD
Agomelatine—Hallucination—Carmustine—malignant glioma	0.00246	0.0181	CcSEcCtD
Agomelatine—Connective tissue disorder—Carmustine—malignant glioma	0.00243	0.0179	CcSEcCtD
Agomelatine—Hepatitis—Temozolomide—malignant glioma	0.00239	0.0176	CcSEcCtD
Agomelatine—Hallucination—Temozolomide—malignant glioma	0.00238	0.0175	CcSEcCtD
Agomelatine—Connective tissue disorder—Temozolomide—malignant glioma	0.00235	0.0173	CcSEcCtD
Agomelatine—HTR2B—brain—malignant glioma	0.00232	0.0107	CbGeAlD
Agomelatine—Eye disorder—Carmustine—malignant glioma	0.00231	0.017	CcSEcCtD
Agomelatine—Eye disorder—Temozolomide—malignant glioma	0.00224	0.0164	CcSEcCtD
Agomelatine—Tinnitus—Temozolomide—malignant glioma	0.00223	0.0164	CcSEcCtD
Agomelatine—Mental disorder—Carmustine—malignant glioma	0.00217	0.0159	CcSEcCtD
Agomelatine—Mental disorder—Temozolomide—malignant glioma	0.0021	0.0154	CcSEcCtD
Agomelatine—Nabumetone—PTGS2—malignant glioma	0.00209	0.0696	CrCbGaD
Agomelatine—Back pain—Carmustine—malignant glioma	0.00208	0.0153	CcSEcCtD
Agomelatine—Vision blurred—Carmustine—malignant glioma	0.00203	0.0149	CcSEcCtD
Agomelatine—Tremor—Carmustine—malignant glioma	0.00202	0.0148	CcSEcCtD
Agomelatine—Back pain—Temozolomide—malignant glioma	0.00201	0.0148	CcSEcCtD
Agomelatine—Agitation—Carmustine—malignant glioma	0.00198	0.0145	CcSEcCtD
Agomelatine—Vision blurred—Temozolomide—malignant glioma	0.00196	0.0144	CcSEcCtD
Agomelatine—Tremor—Temozolomide—malignant glioma	0.00195	0.0143	CcSEcCtD
Agomelatine—Agitation—Temozolomide—malignant glioma	0.00191	0.014	CcSEcCtD
Agomelatine—Angioedema—Temozolomide—malignant glioma	0.0019	0.014	CcSEcCtD
Agomelatine—Vertigo—Temozolomide—malignant glioma	0.00187	0.0137	CcSEcCtD
Agomelatine—Indomethacin—PPARG—malignant glioma	0.00186	0.0618	CrCbGaD
Agomelatine—Anxiety—Carmustine—malignant glioma	0.00183	0.0134	CcSEcCtD
Agomelatine—Anxiety—Temozolomide—malignant glioma	0.00177	0.013	CcSEcCtD
Agomelatine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.00176	0.0129	CcSEcCtD
Agomelatine—Infection—Carmustine—malignant glioma	0.00175	0.0128	CcSEcCtD
Agomelatine—Dry mouth—Temozolomide—malignant glioma	0.00173	0.0127	CcSEcCtD
Agomelatine—Naproxen—PTGS1—malignant glioma	0.00169	0.0563	CrCbGaD
Agomelatine—Infection—Temozolomide—malignant glioma	0.00169	0.0124	CcSEcCtD
Agomelatine—Nervous system disorder—Temozolomide—malignant glioma	0.00167	0.0122	CcSEcCtD
Agomelatine—Skin disorder—Temozolomide—malignant glioma	0.00165	0.0121	CcSEcCtD
Agomelatine—Hyperhidrosis—Temozolomide—malignant glioma	0.00164	0.0121	CcSEcCtD
Agomelatine—Insomnia—Carmustine—malignant glioma	0.00159	0.0117	CcSEcCtD
Agomelatine—Paraesthesia—Carmustine—malignant glioma	0.00158	0.0116	CcSEcCtD
Agomelatine—Somnolence—Carmustine—malignant glioma	0.00156	0.0115	CcSEcCtD
Agomelatine—Insomnia—Temozolomide—malignant glioma	0.00154	0.0113	CcSEcCtD
Agomelatine—Paraesthesia—Temozolomide—malignant glioma	0.00153	0.0112	CcSEcCtD
Agomelatine—Gastrointestinal disorder—Carmustine—malignant glioma	0.00152	0.0111	CcSEcCtD
Agomelatine—Somnolence—Temozolomide—malignant glioma	0.00151	0.0111	CcSEcCtD
Agomelatine—Constipation—Carmustine—malignant glioma	0.0015	0.011	CcSEcCtD
Agomelatine—Dyspepsia—Temozolomide—malignant glioma	0.0015	0.011	CcSEcCtD
Agomelatine—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00147	0.0108	CcSEcCtD
Agomelatine—Fatigue—Temozolomide—malignant glioma	0.00146	0.0108	CcSEcCtD
Agomelatine—Constipation—Temozolomide—malignant glioma	0.00145	0.0107	CcSEcCtD
Agomelatine—Gastrointestinal pain—Carmustine—malignant glioma	0.00144	0.0106	CcSEcCtD
Agomelatine—Abdominal pain—Carmustine—malignant glioma	0.00139	0.0102	CcSEcCtD
Agomelatine—Gastrointestinal pain—Temozolomide—malignant glioma	0.00139	0.0102	CcSEcCtD
Agomelatine—Indomethacin—PTGS1—malignant glioma	0.00137	0.0456	CrCbGaD
Agomelatine—Urticaria—Temozolomide—malignant glioma	0.00135	0.00991	CcSEcCtD
Agomelatine—Abdominal pain—Temozolomide—malignant glioma	0.00134	0.00986	CcSEcCtD
Agomelatine—Asthenia—Carmustine—malignant glioma	0.00126	0.00926	CcSEcCtD
Agomelatine—Asthenia—Temozolomide—malignant glioma	0.00122	0.00895	CcSEcCtD
Agomelatine—Diarrhoea—Carmustine—malignant glioma	0.0012	0.00883	CcSEcCtD
Agomelatine—Pruritus—Temozolomide—malignant glioma	0.0012	0.00883	CcSEcCtD
Agomelatine—Dizziness—Carmustine—malignant glioma	0.00116	0.00854	CcSEcCtD
Agomelatine—Diarrhoea—Temozolomide—malignant glioma	0.00116	0.00854	CcSEcCtD
Agomelatine—Dizziness—Temozolomide—malignant glioma	0.00112	0.00825	CcSEcCtD
Agomelatine—Vomiting—Carmustine—malignant glioma	0.00112	0.00821	CcSEcCtD
Agomelatine—Headache—Carmustine—malignant glioma	0.0011	0.00809	CcSEcCtD
Agomelatine—Vomiting—Temozolomide—malignant glioma	0.00108	0.00793	CcSEcCtD
Agomelatine—Headache—Temozolomide—malignant glioma	0.00106	0.00782	CcSEcCtD
Agomelatine—Nausea—Carmustine—malignant glioma	0.00104	0.00767	CcSEcCtD
Agomelatine—Nausea—Temozolomide—malignant glioma	0.00101	0.00741	CcSEcCtD
Agomelatine—Naproxen—PTGS2—malignant glioma	0.000969	0.0322	CrCbGaD
Agomelatine—Indomethacin—PTGS2—malignant glioma	0.000785	0.0261	CrCbGaD
Agomelatine—CYP1A2—Metabolism—COX8A—malignant glioma	0.000105	0.000459	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—ASMT—malignant glioma	0.000105	0.000457	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—MMP9—malignant glioma	0.000104	0.000452	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—MMP9—malignant glioma	0.000104	0.000452	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—PTEN—malignant glioma	0.000103	0.000449	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—PTEN—malignant glioma	0.000103	0.000449	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—HIST1H3B—malignant glioma	0.000103	0.000449	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	0.000102	0.000446	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling by GPCR—AKT1—malignant glioma	0.000101	0.000438	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling by GPCR—AKT1—malignant glioma	0.000101	0.000438	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—H3F3A—malignant glioma	9.86e-05	0.00043	CbGpPWpGaD
Agomelatine—HTR2C—GPCR ligand binding—CXCL8—malignant glioma	9.85e-05	0.000429	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—BCAN—malignant glioma	9.85e-05	0.000429	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—MMP3—malignant glioma	9.84e-05	0.000429	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—F2—malignant glioma	9.79e-05	0.000427	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—CXCR3—malignant glioma	9.77e-05	0.000426	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—YWHAE—malignant glioma	9.5e-05	0.000414	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—NTRK2—malignant glioma	9.5e-05	0.000414	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—FLT1—malignant glioma	9.46e-05	0.000412	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—DUSP6—malignant glioma	9.42e-05	0.00041	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	9.41e-05	0.00041	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—JAG2—malignant glioma	9.41e-05	0.00041	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—PIK3CG—malignant glioma	9.37e-05	0.000408	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—VEGFA—malignant glioma	9.32e-05	0.000406	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—VEGFA—malignant glioma	9.32e-05	0.000406	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—JAG1—malignant glioma	9.3e-05	0.000405	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—NOTCH3—malignant glioma	9.26e-05	0.000404	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—STAT3—malignant glioma	9.22e-05	0.000402	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—STAT3—malignant glioma	9.22e-05	0.000402	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—FBXW7—malignant glioma	9.11e-05	0.000397	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—ASMT—malignant glioma	8.95e-05	0.00039	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—BDKRB2—malignant glioma	8.94e-05	0.000389	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—F2—malignant glioma	8.89e-05	0.000388	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	8.75e-05	0.000381	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—AKT2—malignant glioma	8.58e-05	0.000374	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—MYC—malignant glioma	8.57e-05	0.000373	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—MYC—malignant glioma	8.57e-05	0.000373	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—PIK3CG—malignant glioma	8.51e-05	0.000371	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—BCAN—malignant glioma	8.42e-05	0.000367	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—EGFR—malignant glioma	8.38e-05	0.000365	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—EGFR—malignant glioma	8.38e-05	0.000365	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—PTPN11—malignant glioma	8.36e-05	0.000364	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—NOTCH2—malignant glioma	8.31e-05	0.000362	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—PIK3CD—malignant glioma	8.24e-05	0.000359	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—KNG1—malignant glioma	8.13e-05	0.000354	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—H3F3A—malignant glioma	7.96e-05	0.000347	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—IDH2—malignant glioma	7.94e-05	0.000346	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—KRAS—malignant glioma	7.92e-05	0.000345	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—KRAS—malignant glioma	7.92e-05	0.000345	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—F2—malignant glioma	7.9e-05	0.000344	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—CXCR3—malignant glioma	7.88e-05	0.000343	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—AKT2—malignant glioma	7.79e-05	0.000339	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—NTRK1—malignant glioma	7.75e-05	0.000338	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—NTRK2—malignant glioma	7.67e-05	0.000334	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—YWHAE—malignant glioma	7.67e-05	0.000334	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—FLT1—malignant glioma	7.63e-05	0.000333	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—DUSP6—malignant glioma	7.6e-05	0.000331	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—PIK3CG—malignant glioma	7.56e-05	0.000329	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—JAG1—malignant glioma	7.5e-05	0.000327	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	7.49e-05	0.000326	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—PIK3CD—malignant glioma	7.48e-05	0.000326	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—NOTCH3—malignant glioma	7.47e-05	0.000326	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—CYP2B6—malignant glioma	7.47e-05	0.000325	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—FBXW7—malignant glioma	7.35e-05	0.00032	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—PIK3CA—malignant glioma	7.28e-05	0.000317	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—PIK3CA—malignant glioma	7.28e-05	0.000317	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—BDKRB2—malignant glioma	7.21e-05	0.000314	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—MMP3—malignant glioma	7.2e-05	0.000314	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—PIK3CB—malignant glioma	7.18e-05	0.000313	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—F2—malignant glioma	7.18e-05	0.000313	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—CDKN2B—malignant glioma	7.14e-05	0.000311	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—TP53—malignant glioma	7.04e-05	0.000307	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—TP53—malignant glioma	7.04e-05	0.000307	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—PTK2—malignant glioma	6.93e-05	0.000302	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—AKT2—malignant glioma	6.92e-05	0.000301	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—CXCL8—malignant glioma	6.9e-05	0.000301	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—PIK3CG—malignant glioma	6.87e-05	0.000299	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—IDH1—malignant glioma	6.83e-05	0.000297	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—HES1—malignant glioma	6.81e-05	0.000297	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—IDH2—malignant glioma	6.79e-05	0.000296	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—NCOR1—malignant glioma	6.77e-05	0.000295	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—PTPN11—malignant glioma	6.75e-05	0.000294	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—NOTCH2—malignant glioma	6.7e-05	0.000292	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—RAF1—malignant glioma	6.68e-05	0.000291	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—PIK3CD—malignant glioma	6.65e-05	0.00029	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—SPHK1—malignant glioma	6.61e-05	0.000288	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—IL2—malignant glioma	6.6e-05	0.000287	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—KNG1—malignant glioma	6.56e-05	0.000286	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—PIK3CB—malignant glioma	6.52e-05	0.000284	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—PDGFRA—malignant glioma	6.49e-05	0.000283	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—CYP2C18—malignant glioma	6.47e-05	0.000282	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	6.4e-05	0.000279	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—CYP2B6—malignant glioma	6.38e-05	0.000278	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—SPP1—malignant glioma	6.3e-05	0.000274	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—AKT2—malignant glioma	6.28e-05	0.000274	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—CXCL8—malignant glioma	6.27e-05	0.000273	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—NTRK1—malignant glioma	6.25e-05	0.000272	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	6.1e-05	0.000266	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—PIK3CD—malignant glioma	6.04e-05	0.000263	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—IL2—malignant glioma	5.99e-05	0.000261	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—TERT—malignant glioma	5.97e-05	0.00026	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—AKT1—malignant glioma	5.94e-05	0.000259	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—AKT1—malignant glioma	5.94e-05	0.000259	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—IDH1—malignant glioma	5.83e-05	0.000254	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—PDGFB—malignant glioma	5.83e-05	0.000254	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—MMP3—malignant glioma	5.81e-05	0.000253	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—FGFR1—malignant glioma	5.8e-05	0.000252	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—PIK3CB—malignant glioma	5.79e-05	0.000252	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—CDKN2B—malignant glioma	5.76e-05	0.000251	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—HIF1A—malignant glioma	5.71e-05	0.000249	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—SPHK1—malignant glioma	5.65e-05	0.000246	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—PTK2—malignant glioma	5.59e-05	0.000244	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—CXCL8—malignant glioma	5.57e-05	0.000243	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	5.56e-05	0.000242	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—CYP2C18—malignant glioma	5.53e-05	0.000241	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—CAV1—malignant glioma	5.52e-05	0.000241	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—HES1—malignant glioma	5.49e-05	0.000239	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—NCOR1—malignant glioma	5.46e-05	0.000238	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—KDR—malignant glioma	5.46e-05	0.000238	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—RAF1—malignant glioma	5.39e-05	0.000235	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	5.37e-05	0.000234	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—IL2—malignant glioma	5.32e-05	0.000232	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—PIK3CB—malignant glioma	5.26e-05	0.000229	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—F2—malignant glioma	5.25e-05	0.000229	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—FN1—malignant glioma	5.25e-05	0.000229	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—GSTT1—malignant glioma	5.24e-05	0.000228	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—PDGFRA—malignant glioma	5.23e-05	0.000228	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	5.22e-05	0.000227	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—BAD—malignant glioma	5.19e-05	0.000226	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—NOTCH1—malignant glioma	5.14e-05	0.000224	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—SPP1—malignant glioma	5.08e-05	0.000221	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—CXCL8—malignant glioma	5.06e-05	0.00022	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—CD80—malignant glioma	5.04e-05	0.000219	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—APC—malignant glioma	5.03e-05	0.000219	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—PIK3CG—malignant glioma	5.03e-05	0.000219	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—EGF—malignant glioma	4.97e-05	0.000217	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—PTPN11—malignant glioma	4.94e-05	0.000215	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—PTGS1—malignant glioma	4.91e-05	0.000214	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	4.89e-05	0.000213	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—IL2—malignant glioma	4.83e-05	0.000211	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—TERT—malignant glioma	4.82e-05	0.00021	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	4.75e-05	0.000207	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—BRAF—malignant glioma	4.73e-05	0.000206	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—PDGFB—malignant glioma	4.7e-05	0.000205	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—FGFR1—malignant glioma	4.68e-05	0.000204	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—HIF1A—malignant glioma	4.6e-05	0.000201	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—AKT2—malignant glioma	4.6e-05	0.0002	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	4.59e-05	0.0002	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—EGFR—malignant glioma	4.58e-05	0.0002	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—BCHE—malignant glioma	4.56e-05	0.000199	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—SLC5A5—malignant glioma	4.5e-05	0.000196	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—GSTT1—malignant glioma	4.47e-05	0.000195	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—CAV1—malignant glioma	4.45e-05	0.000194	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—PIK3CD—malignant glioma	4.42e-05	0.000193	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—KDR—malignant glioma	4.4e-05	0.000192	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—PIK3CA—malignant glioma	4.38e-05	0.000191	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—KRAS—malignant glioma	4.33e-05	0.000189	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	4.26e-05	0.000186	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—F2—malignant glioma	4.24e-05	0.000185	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—FN1—malignant glioma	4.24e-05	0.000185	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—FGF2—malignant glioma	4.23e-05	0.000184	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	4.22e-05	0.000184	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—PTGS1—malignant glioma	4.19e-05	0.000183	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—BAD—malignant glioma	4.19e-05	0.000183	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	4.18e-05	0.000182	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—NOTCH1—malignant glioma	4.15e-05	0.000181	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—CD80—malignant glioma	4.06e-05	0.000177	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—APC—malignant glioma	4.06e-05	0.000177	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—PIK3CG—malignant glioma	4.06e-05	0.000177	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—EGF—malignant glioma	4.01e-05	0.000175	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—PTPN11—malignant glioma	3.99e-05	0.000174	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—PIK3CA—malignant glioma	3.98e-05	0.000173	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—MDM2—malignant glioma	3.96e-05	0.000173	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—RAF1—malignant glioma	3.95e-05	0.000172	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—ERBB2—malignant glioma	3.9e-05	0.00017	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—BCHE—malignant glioma	3.9e-05	0.00017	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—PIK3CB—malignant glioma	3.85e-05	0.000168	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—SLC5A5—malignant glioma	3.85e-05	0.000168	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—BRAF—malignant glioma	3.81e-05	0.000166	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—AKT2—malignant glioma	3.71e-05	0.000162	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—CXCL8—malignant glioma	3.7e-05	0.000161	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—EGFR—malignant glioma	3.7e-05	0.000161	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	3.68e-05	0.00016	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	3.64e-05	0.000159	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—GSTP1—malignant glioma	3.63e-05	0.000158	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	3.61e-05	0.000157	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—AKT1—malignant glioma	3.58e-05	0.000156	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—PIK3CD—malignant glioma	3.57e-05	0.000155	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—CASP3—malignant glioma	3.54e-05	0.000154	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—IL2—malignant glioma	3.54e-05	0.000154	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—PIK3CA—malignant glioma	3.53e-05	0.000154	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—CAT—malignant glioma	3.53e-05	0.000154	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—KRAS—malignant glioma	3.49e-05	0.000152	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—FGF2—malignant glioma	3.41e-05	0.000149	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—MMP9—malignant glioma	3.35e-05	0.000146	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—NCOR1—malignant glioma	3.33e-05	0.000145	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—PTEN—malignant glioma	3.33e-05	0.000145	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—AKT1—malignant glioma	3.25e-05	0.000142	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—PIK3CA—malignant glioma	3.21e-05	0.00014	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—MDM2—malignant glioma	3.19e-05	0.000139	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—RAF1—malignant glioma	3.18e-05	0.000139	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—ERBB2—malignant glioma	3.15e-05	0.000137	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	3.15e-05	0.000137	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—PIK3CB—malignant glioma	3.11e-05	0.000135	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—GSTP1—malignant glioma	3.1e-05	0.000135	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—CAT—malignant glioma	3.02e-05	0.000131	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—VEGFA—malignant glioma	3.01e-05	0.000131	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—CXCL8—malignant glioma	2.99e-05	0.00013	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—STAT3—malignant glioma	2.98e-05	0.00013	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—AKT1—malignant glioma	2.89e-05	0.000126	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—CASP3—malignant glioma	2.86e-05	0.000125	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—IL2—malignant glioma	2.85e-05	0.000124	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—NCOR1—malignant glioma	2.85e-05	0.000124	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—MYC—malignant glioma	2.77e-05	0.000121	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—CAV1—malignant glioma	2.72e-05	0.000118	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—EGFR—malignant glioma	2.71e-05	0.000118	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—MMP9—malignant glioma	2.7e-05	0.000118	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—PTEN—malignant glioma	2.69e-05	0.000117	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—AKT1—malignant glioma	2.62e-05	0.000114	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	2.6e-05	0.000113	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—KRAS—malignant glioma	2.56e-05	0.000111	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—PIK3CG—malignant glioma	2.48e-05	0.000108	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—VEGFA—malignant glioma	2.43e-05	0.000106	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—STAT3—malignant glioma	2.4e-05	0.000105	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—PPARG—malignant glioma	2.39e-05	0.000104	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—PIK3CA—malignant glioma	2.35e-05	0.000102	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—CAV1—malignant glioma	2.32e-05	0.000101	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—TP53—malignant glioma	2.27e-05	9.9e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—MYC—malignant glioma	2.23e-05	9.73e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	2.22e-05	9.67e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—EGFR—malignant glioma	2.18e-05	9.51e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—PIK3CD—malignant glioma	2.18e-05	9.48e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—PIK3CG—malignant glioma	2.12e-05	9.22e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—KRAS—malignant glioma	2.06e-05	8.99e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—PPARG—malignant glioma	2.04e-05	8.9e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—AKT1—malignant glioma	1.92e-05	8.36e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—PIK3CB—malignant glioma	1.9e-05	8.27e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—PIK3CA—malignant glioma	1.89e-05	8.26e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—PTGS2—malignant glioma	1.88e-05	8.19e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—PIK3CD—malignant glioma	1.86e-05	8.1e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—TP53—malignant glioma	1.83e-05	7.99e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—PTEN—malignant glioma	1.64e-05	7.14e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—PIK3CB—malignant glioma	1.62e-05	7.06e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—PTGS2—malignant glioma	1.61e-05	7e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—AKT1—malignant glioma	1.55e-05	6.74e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—PTEN—malignant glioma	1.4e-05	6.1e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—PIK3CA—malignant glioma	1.16e-05	5.04e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—PIK3CA—malignant glioma	9.88e-06	4.31e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—AKT1—malignant glioma	9.45e-06	4.12e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—AKT1—malignant glioma	8.07e-06	3.52e-05	CbGpPWpGaD
